DAFTAR PUSTAKA

Alberti-Violetti S, Talpur R, Schlichte M, Sui D, Duvic M. 2015. Advanced-stage

mycosis fungoides and Sézary syndrome: survival and response to
treatment. Clin Lymphoma Myeloma Leuk. 15(6):e105-12.
Allanore, L.V., Roujeau, J.C. 2012. Epidermal necrolysis (Steven-Johnson
syndrome and toxic epidermal necrolysis). Dalam: Wolff K, Goldsmith L,
Katz S, Gilchrest B, Paller A, Leffel D, editors. Fitzpatrick‟s dermatology
in general medicine. Edisi ke 8. New York: McGraw-Hill.hal.439448.
Armstrong AW, Bagel J, Van Voorhees AS, Robertson AD, Yamauchi PS. 2015.
Combining biologic therapies with other systemic treatments in psoriasis:
evidence-based, best-practice recommendations from the Medical Board of
the National Psoriasis Foundation. JAMA Dermatol. 151(4):432-8.
Bosseila M, Mahgoub D, El-Sayed A, Salama D, Abd El-Moneim M, Al-Helf F.
2014. Does fluorescence diagnosis have a role in follow up of response to
therapy in mycosis fungoides?. Photodiagnosis Photodyn Ther. 11(4):595-
602.
Cohen V. 2018. Toxic Epidermal Necrolysis (TEN): Background,
Pathophysiology, Etiology Medscape. Available from:
https://emedicine.medscape.com/article/229698-overview.
Creamer, D., Walsh, S.A., Dziewulski, P., et al. 2016. UK guidelines for the
management of StevensJohnson syndrome/toxic epidermal necrolysis in
adults 2016. Br J Dermatol. Vol. 174: 1194-1227.
De, A., Rajagopalan, M., Sarda, A., Das, S., and Biswas, P. 2018. Drug Reaction
with Eosinophilia and Systemic Symptoms: An Update and Review of
Recent Literature. Indian journal of dermatology. 63(1): 30–40.
https://doi.org/10.4103/ijd.IJD_582_17.
Doukaki S, Aricò M, Bongiorno MR. 2010. Erythroderma related to the
administration of 99mTc-sestamibi: the first report. J Nucl Cardiol. 17(3):
520-2.
Dwi, A., Thaha, A., Hari, M.I. 2015. Angka Kejadian dan Faktor Penyebab
Eritroderma di Poliklinik Ilmu Kesehatan Kulit dan Kelamin RSUP Dr.
Mohammad Hoesin Palembang Periode 2009-2011. MKS. 47 (2): 79 – 84.
Estrella-Alonso, A., Aramburu, J., González-Ruiz, M., Cachafeiro, L., Sánchez
Sánchez, M., and Lorente, J. 2017. Toxic epidermal necrolysis: a paradigm
of critical illness. Revista Brasileira de Terapia Intensiva. 29 (4): 499-508.
Foster CS, Ba-Abbad R, Letko E, et all. 2016. Stevens-Johnson Syndrome.
Medscape. Diunduh dari: https://emedicine.medscape.com/article/1197450.
French LE and Prins C. 2013. Erythema multiforme, stevens johnson syndrome
and toxic epidermal necrolysis.. New York: Elsevier.
Frey, N., Jossi, J., Bodmer, M., Bircher, A., Jick, S., Meier, C.T., and Spoendlin,
J. 2017. The Epidemiology of Stevens-Johnson Syndrome and Toxic
Epidermal Necrolysis in the UK. Journal of Investigative Dermatology. 137
(6): 1240-1247.
Gros A, Laharanne E, Vergier M, Prochazkova-Carlotti M, Pham-Ledard A,
Bandres T, et all. 2017. TP53 alterations in primary and secondary Sézary
syndrome: A diagnostic tool for the assessment of malignancy in patients
with erythroderma. PLoS One. 12 (3):e0173171.
Guttman-Yassky E, Dhingra N, Leung DY. 2013. New era of biologic
therapeutics in atopic dermatitis. Expert Opin Biol Ther. 13(4):549-61.
Hamm R. L. 2012. Drug-hypersensitivity syndrome: diagnosis and treatment. The
journal of the American College of Clinical Wound Specialists. 3(4): 77–81.
https://doi.org/10.1016/j.jcws.2012.0.
Hammers, C. M., and Stanley, J. R. 2016. Mechanisms of Disease: Pemphigus
and Bullous Pemphigoid. Annual review of pathology. 11: 175–197.
https://doi.org/10.1146/annurev-pathol-012615-044313
Harr, T., French, L.E. 2010. Toxic epidermal necrolysis and Steven-Johnson
syndrome. Orphanet J Rare Dis. Vol.5:39.
Hoetzenecker, W., Mehra, T., Saulite, I., Glatz, M., Schmid-Grendelmeier, P.,
Guenova, E., Cozzio, A., and French, L. E. 2016. Toxic epidermal
necrolysis. F1000Research. 5: 951.
https://doi.org/10.12688/f1000research.7574.1.
Hughes CF, Khot A, McCormack C, Lade S, Westerman DA, Twigger R, et all.
2015. Lack of durable disease control with chemotherapy for mycosis
fungoides and Sézary syndrome: a comparative study of systemic therapy.
Blood. 125(1):71-81.
Humme D, Nast A, Erdmann R, Vandersee S, Beyer M. 2014. Systematic review
of combination therapies for mycosis fungoides. Cancer Treat Rev. 40(8):
927-33.
Husain Z, Reddy BY, Schwartz RA. 2013. DRESS syndrome: Part I. Clinical
perspectives. J Am Acad Dermatol. 68:693. e1-1.
Husain Z, Reddy BY, Schwartz RA. 2013. Dress syndrome Part II. Management
and therapeutics. J Am Acad Dermatol. 709: e1-9.
Jusufbegovic D and Char DH. 2015 Clinical variability of ocular involvement in
mycosis fungoides. JAMA Ophthalmol. 133(3): 341-3.
Kinoshita Y, and Saeki H. 2016. A Review of the Pathogenesis of Toxic
Epidermal Necrolysis. Journal of Nippon Medical School. 83 (6): 216-222.
Kirsch IR, Watanabe R, O'Malley JT, Williamson DW, Scott LL, Elco CP, et all.
2015. TCR sequencing facilitates diagnosis and identifies mature T cells as
the cell of origin in CTCL. Sci Transl Med. 7(308): 308ra158.
Kridin K, Sagi SZ, Bergman R. 2017. Mortality and cause of death in Israeli
patients with pemphigus. Acta Derm Venereol. 97:607–611.
Lancrajan C, Bumbacea R, Giurcaneanu C. 2010. Erythrodermic atopic dermatitis
with late onset--case presentation. J Med Life. 3(1):80-3
Lai O, Recke A, Zillikens D, Kasperkiewicz M. 2018. Influence of cigarette
smoking on pemphigus - a systematic review and pooled analysis of the
literature. J Eur Acad Dermatol Venereol. 32: 1256–1262.
Lee WK, Kim GW, Cho HH, Kim WJ, Mun JH, Song M, et all. 2015.
Erythrodermic psoriasis treated with golimumab: a case report. Ann
Dermatol. 27(4):446-9.
Lehloenya, R.J. 2011. Cutaneous adverse drug reactions. CME. Vol.29(6):238-42.
Magana, B.R.D., Langner, A.L., et al. 2011. A systematic review of treatment of
drug-induced StevenJohnson syndrome and toxic epidermal necrolysis in
children. J Popul Ther Clin Pharmacol. Vol.18(1):121-133.
Mateo S, García-Martínez FJ, Sánchez-Aguilar D, Amarelo J, Toribio J. 2014.
Psoriasiform exfoliative erythroderma induced by golimumab. Clin Exp
Dermatol. 39(7):813-15.
Maverakis, E., Wang, E., Shinkai, K., Mahasirimongkol, S., Margolis, D., Avigan,
M., Chung, W., Goldman, J., Grenade, L., Pirmohamed, M., Shear, N.,
Tassaneeyakul, W., Hoetzenecker, W., Klaewsongkram, J.,
Rerkpattanapipat, T., Manuyakorn, W., Yasuda, S., Sharon, V., Sukhov, A.,
and Cheng, M. 2017. Stevens-Johnson Syndrome and Toxic Epidermal
Necrolysis Standard Reporting and Evaluation Guidelines. JAMA
Dermatology. 153 (6): 587.
Megna M, Sidikov AA, Zaslavsky DV, Chuprov IN, Timoshchuk EA, Egorova U,
et all. 2017. The role of histological presentation in erythroderma. Int J
Dermatol. 56 (4):400-404.
Meshram, G. G., Kaur, N., & Hura, K. S. 2018. Staphylococcal scalded skin
syndrome: A pediatric dermatology case report. SAGE open medical case
reports. 6: 2050313X17750890.
https://doi.org/10.1177/2050313X17750890.
Mishra, A. K., Yadav, P., and Mishra, A. 2016. A Systemic Review on
Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical
Disease of Neonates. The open microbiology journal. 10: 150–159.
https://doi.org/10.2174/1874285801610010150.
Mockenhaupt M. 2014. Stevens-Johnson syndrome and toxic epidermal
necrolysis: clinical patterns, diagnostic considerations, etiology, and
therapeutic management. Semin Cutan Med Surg. 33(1):1-6
Nirken MH, High WA, Adkinson NF, et all. 2017. Stevens-Johnson syndrome
and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and
diagnosis. UpToDate. Diunduh dari:
https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-
epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis.
Nishifuji K., Shimizu A., Ishiko A., Iwasaki T., Amagai M. 2010. Removal of
amino-terminal extracellular domains of desmoglein 1 by staphylococcal
exfoliative toxin is sufficient to initiate epidermal blister formation. J.
Dermatol. Sci. 59 (3) :184–191. doi: 10.1016/j.jdermsci.2010.07.010.
Nishizawa A, Igawa K, Teraki H, Yokozeki H. 2014. Diffuse disseminated
lichenoid-type cutaneous sarcoidosis mimicking erythroderma. Int J
Dermatol. 53(8):e369-70.
Ohga, Y., Bayaraa, B., and Imafuku, S. 2018. Chronic idiopathic erythroderma of
elderly men is an independent entity that has a distinct TARC/IgE profile
from adult atopic dermatitis. Int J Dermatol. 57 (6):670-674.
Ohga Y, Bayaraa B, Imafuku S. 2019. Therapeutic options and prognosis of
chronic idiopathic erythroderma in older adults. Dermatol Ther. 32
(4):e12977
Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). 2017.
Panduan Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di
Indonesia. Jakarta: Perhimpunan Dokter Spesialis Kulit dan Kelamin
Indonesia.
Porro, A. M., Seque, C. A., Ferreira, M., and Enokihara, M. 2019. Pemphigus
vulgaris. Anais brasileiros de dermatologia, 94(3), 264–278.
https://doi.org/10.1590/abd1806-4841.20199011
Rajaratnam, R., Mann, C., Balasubramaniam, P., Marsden, J., Taibjee, S., Shah,
F., et al. 2010. Toxic epidermal necrolysis: retrospective analysis of 21
consecutive cases managed at a tertiary centre. Clin Exp Dermatol.
Vol.35(8):853-62.
Ram-Wolff C, Martin-Garcia N, Bensussan A, Bagot M, Ortonne N. 2010.
Histopathologic diagnosis of lymphomatous versus inflammatory
erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am
J Dermatopathol. 32(8):755-63.
Sbidian E, Battistella M, Rivet J, Flageul B, Molina JM, Joly P, et all. 2010.
Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in
human immunodeficiency virus-infected patients receiving highly active
antiretroviral therapy. Clin Infect Dis. 51(6): 741-8.
Schwartz, R., McDonough, P., and Lee, B. 2013. Toxic epidermal necrolysis.
Journal of the American Academy of Dermatology. 69 (2): 187.e1-187.e16.
Singalavanija, S. and Limpongsanurak, W. 2011. Stevens-Johnson syndrome in
Thai children: a 29-year study. J Med Assoc Thai. 94 suppl 3:S85-90.
Singh GK, Chatterjee M, Verma R. 2013. Cyclosporine in Stevens Johnson
syndrome and toxic epidermal necrolysis and retrospective comparison with
systemic corticosteroid. Indian J Dermatol Venereol Leprol. 79(5): 686-92
Spicknall, K.E. 2018. Sézary syndrome-clinical and histopathologic features,
differential diagnosis, and treatment. Semin Cutan Med Surg. 37 (1):18-23.
Suwarsa, O., Yuwita, W., Dharmadji, H.P., Sutedja, E. 2016. Stevens-Johnson
syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General
Hospital Bandung, Indonesia from 2009-2013. Asian. Pac. J. Allergy
Immunol.
Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maitre B, Revuz J,
Bagot M, Roujeau J. 2010. Open trial of ciclosporin treatment for Stevens-
Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 163(4):
847-853.
Verma P, Bhattacharya SN, Banerjee BD, Khanna N. 2012. Oxidative stress and
leukocyte migration inhibition response in cutaneous adverse drug reactions.
Indian J Dermatol Venereol Leprol. 78(5): 664.
Verma CR, Vasudevan B, Vjiendran P. 2013. Severe cutaneous adverse drug
reactions. Med J Armed Forces India. (69): 375-83
Wiedemann K., Schmid C., Hamm H., Wirbelauer J. 2016. Staphylococcal
scalded skin syndrome in a very low birth weight premature infant. Z.
Geburtshilfe Neonatol. 220(1): 35–38
Wilcox RA. 2016. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-
stratification, and management. Am J Hematol. 91(1):151-65.
Witari, K.A. 2019. Diagnosis dan tatalaksana Sindroma Stevens-Johnson (SJS)
pada anak: tinjauan pustaka. Intisari Sains Medis. 10 (3): 592-596. DOI:
10.15562/ism.v10i3.588.
Yuan XY, Guo JY, Dang YP, Qiao L, Liu W. 2010. Erythroderma: A clinical-
etiological study of 82 cases. Eur J Dermatol. 20(3): 373-7.